Satellos Bioscience Inc. - MSLE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | Brian Matthew Bloom | 7.35% | 1,133,401 | View |
| May 15, 2026 | SCHEDULE 13G | Bloom Burton & Co. Inc. | 6.53% | 1,010,167 | View |
| May 15, 2026 | SCHEDULE 13G | Jolyon David Burton | 6.53% | 1,010,167 | View |
| May 12, 2026 | SCHEDULE 13G | Qiming U.S. Healthcare Fund III, L.P. | 8.3% | 1,725,247 | View |
| May 12, 2026 | SCHEDULE 13G | Qiming U.S. Healthcare GP III, LLC | 8.3% | 1,725,247 | View |
| May 12, 2026 | SCHEDULE 13G | Mark McDade | 8.3% | 1,725,247 | View |
| May 12, 2026 | SCHEDULE 13G | GARY E RIESCHEL | 8.3% | 1,725,247 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.